Xiangbin Wu
- Topics
- Circular RNAs in diseases (3 papers)Cancer-related molecular mechanisms research (3 papers)RNA modifications and cancer (2 papers)
In The Last Decade
Xiangbin Wu
9 papers receiving 284 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 146
- Oncology 120
- Cancer Research 105
- Immunology 64
- Surgery 28
Countries citing papers authored by Xiangbin Wu
This map shows the geographic impact of Xiangbin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangbin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangbin Wu more than expected).
Fields of papers citing papers by Xiangbin Wu
This network shows the impact of papers produced by Xiangbin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangbin Wu. The network helps show where Xiangbin Wu may publish in the future.
Co-authorship network of co-authors of Xiangbin Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangbin Wu. A scholar is included among the top collaborators of Xiangbin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangbin Wu. Xiangbin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | m(6)A demethylase ALKBH5 inhibits cell proliferation and the metastasis of colorectal cancer by regulating the FOXO3/miR-21/SPRY2 axis. | 18 |
| 4 | 103 | |
| 5 | MEG3 can affect the proliferation and migration of colorectal cancer cells through regulating miR-376/PRKD1 axis. | 33 |
| 6 | Upregulation of the long non-coding RNA SPRY4-IT1 predicts poor prognosis in breast cancer. | 5 |
| 7 | 96 | |
| 8 | 20 | |
| 9 | 1 |
About Xiangbin Wu
Xiangbin Wu is a scholar working on Cancer Research, Immunology and Allergy and Statistics, Probability and Uncertainty, having authored 9 papers that have together received 287 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (105 citations), Immunology and Allergy (28 citations) and Oncology (120 citations). Xiangbin Wu has collaborated with scholars based in China and Germany. Frequent co-authors include Jianhui Cai, Zhigui Zuo, Jinlei Li, Jinlei Li, Huayu Song, Limin Xia, Zhenhua Zhou, Qiyu Zhang, Yanjiao Wang and Huayu Zhu. Their work appears in journals such as Medicine, Biomedicine & Pharmacotherapy and Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.